Table 1.
Baseline characteristics
| Tapentadol group (n = 15) | Placebo group (n = 19) | |
|---|---|---|
| Men/women (n) | 1/14 | 1/18 |
| Age (years)—median (range) | 46.2 (23–62) | 42.4 (24–67) |
| Weight (kg)—mean (SD) | 78.7 (17.3) | 81.8 (16.4) |
| Height (cm)—mean (SD) | 1.70 (0.1) | 1.72 (0.1) |
| Widespread Pain Index—mean (SD) | 13.1 (3.0) | 13.5 (3.1) |
| Symptom Severity Score—mean (SD) | 9.2 (1.5) | 8.8 (1.4) |
| Disease duration (years) | 5.4 (4.9) | 4.8 (3.8) |
| PainDetect | ||
| Pain intensity score (mm)—mean (SD) | 62.0 (13.1) | 62.1 (14.0) |
| Neuropathic symptom score—mean (SD) | 19.7 (6.5) | 19.8 (5.8) |
| Score 13–18 (n, %) | 5 (33.3) | 5 (26.3) |
| Score 19–38 (n, %) | 9 (60.0) | 12 (63.2) |
Abbreviation: SD, standard deviation.